Reported by The Hill •
35 Mainstream framing L R No clear lean ✓ verified
Why this rating? · 3 signals

Signals flagged in the original

  • loaded language: 'costly and harmful'
  • framing: Is this the end of costly and harmful pharmaceutical advertising?
  • editorializing: Direct-to-consumer pharmaceutical advertising is under increasing political pressure

Analyzed by our bias model Full breakdown ↓

Legislation Introduced to Address Pharmaceutical Advertising Practices

Bipartisan legislation is being introduced to restrict direct-to-consumer pharmaceutical advertising, amid growing political pressure. States are also considering bills to eliminate tax deductions for advertising expenses in this sector.

Our neutral summary

Bipartisan legislation is being introduced to restrict direct-to-consumer pharmaceutical advertising, amid growing political pressure. States are also considering bills to eliminate tax deductions for advertising expenses in this sector.

Read the full story at The Hill

The reporting belongs to The Hill; we don't reproduce it.

Annotating as

No note attached

on this article.

Language Analysis

Loaded-language score 35/100
wirepublicmainstream flavoredpartisanadvocacy
Inflammatory language 39/100

Loaded Language Removed

  • ✕ loaded language: 'costly and harmful'
  • ✕ framing: Is this the end of costly and harmful pharmaceutical advertising?
  • ✕ editorializing: Direct-to-consumer pharmaceutical advertising is under increasing political pressure

Original vs. Neutral

Original Headline

Is this the end of costly and harmful pharmaceutical advertising?

Neutral Headline

Legislation Introduced to Address Pharmaceutical Advertising Practices